Europe-wide regulation of animals used for scientific purposes made a significant advancement with the adoption of Directive 63/2010/EU in September of 2010. The new directive improved on the previous one, Directive 86/609/EEC, by removing many of the discrepancies in protocols between European nations that often lead to quite obviously varying levels of protection for the […]
The latest FRAME Annual Lecture was a huge success and sparked an in-depth debate on the future of drug development and testing.
Speaker Dr Malcolm Skingle, Director of Academic Liaison at Glaxo Smith Kline, discussed using innovation to promote the Three Rs. He outlined changes in the use of animals to test new drugs and demonstrated […]
FRAME has appointed a new Director to oversee its research programme at the Nottingham office. Dr Gerry Kenna is a drug safety scientist with extensive industrial safety assessment experience, including 11 years in the pharmaceutical industry. Prior to that he had a highly successful academic career. He is recognised nationally and internationally in the field […]
The RSPCA has drawn up a plan that aims to end severe suffering for animals used in research and testing. The road-map has been released in response to changes in EU and UK legislation and has been published in FRAME’s scientific journal ATLA.
Until now scientists have not been required to record how many test animals […]
An abridged version of the book that first set out the Three Rs principles of alternatives to animal experimentation has been translated into Chinese, and will be distributed to libraries and universities throughout China.
China has so far been slow to adopt alternatives – cosmetics testing on animals is still required by law there, for example […]